Pain News and Research

Latest Pain News and Research

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Many Rite Aid pharmacists have already been giving regular seasonal flu shots following the Centers for Disease Control and Prevention (CDC) advice that anyone who wishes to reduce the risk of getting the regular seasonal flu get a flu shot as soon as they are available.

31 Aug 2009

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the “Best New Product” at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.

31 Aug 2009

Health Net urges Americans to have their blood cholesterol measured

Tomorrow, September 1, marks the start of National Cholesterol Education Month. In support of this educational effort, Health Net, Inc., (NYSE: HNT) is encouraging those who haven't yet done so, to have their blood cholesterol measured and, if it's high, to embark on a cholesterol-lowering program.

31 Aug 2009

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company is pleased to announce that the company has signed an agreement with Leading Points Corporation to represent its products, services and initiatives to various government and military agencies.

31 Aug 2009

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders.

31 Aug 2009

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

Sanford Health, a comprehensive health care provider in the Upper Midwest, announced today a spinal implant developed by Sanford Clinic Neurosurgeon, Wilson Asfora, MD, Sanford Clinic Neurosurgery & Spine, has received United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar intervertebral body fusion device.

31 Aug 2009

Rebuilder Medical Technologies is in concluding stages of finalizing a national contract to provide billing services for all physicians

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it is in the final stages of negotiating a national contract to provide all physicians with billing services for Medicare claims for the ReBuilder.

29 Aug 2009

Inhibitor Education Summits to address pertinent topics regarding hemophilia

More than 160 families of patients living with a rare form of hemophilia are coming together at educational summits sponsored this fall by the National Hemophilia Foundation (NHF) and the Center for Biomedical Continuing Education (CBCE). For the fifth year, the Inhibitor Education Summits will connect patients and their families with expert healthcare professionals and fellow patients to address pertinent topics such as effective pain management, exercise and nutrition, financial security, and psychological wellbeing.

29 Aug 2009

New compound discovered by Scripps scientists offers a novel template for drug development

Scientists at Scripps Institution of Oceanography at UC San Diego and their colleagues at Creighton University have deciphered the highly unusual molecular structure of a naturally produced, ocean-based compound that is giving new understanding of the function of mammalian nerve cells.

29 Aug 2009

The Waismann Method of Accelerated Benzodiazepine Neuro-Regulation proves a suitable alternative to traditional benzodiazepine detoxification

The Waismann Method of Accelerated Benzodiazepine Neuro-Regulation (ABNR) involves a safe, medically-assisted withdrawal from Benzodiazepines in a hospital setting. This advanced approach to Benzodiazepine withdrawal offers patients another alternative to traditional benzodiazepine detoxification, which even when done gradually, can be extremely dangerous and even life threatening.

29 Aug 2009

Two new studies from a federal agency point to risks, costs in health care

Two new reports from the Agency for Healthcare Research and Quality made news Thursday. One addresses the consequences of leaving the hospital against the doctor's orders, while the other notes that health spending on seniors rose by over $100 billion between 1996 and 2006.

29 Aug 2009

ReBuilder Medical Technologies reports 100% increase in second-quarter 2009 profits over first-quarter

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has published its second quarter 09 profits and that profits are up 100% over the first quarter.

28 Aug 2009

WERF to assess the hidden cost of endometriosis to society and women with the disease

The World Endometriosis Research Foundation (WERF) has raised sufficient funds to commence the first ever prospective study to assess the hidden cost of endometriosis to society and to women with the disease.

28 Aug 2009

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Measuring circulation in the ankle using a device similar to a blood pressure cuff can help identify asymptomatic peripheral artery disease (PAD) in stroke and transient ischemic attack (TIA) survivors, a group at much higher risk of subsequent cerebrovascular events, according to a study in Stroke: Journal of the American Heart Association.

28 Aug 2009

Distribution agreement signed between Cardiovascular Systems and Asahi Intecc

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed an exclusive distribution agreement with Asahi Intecc Co., Ltd., based in Japan, to market its peripheral guide wire line in the United States.

28 Aug 2009

Rutgers University Professor receives $3.5 million MERIT Award from NIH

Rutgers University Professor Dipak Sarkar has received a $3.5 million MERIT Award from the National Institutes of Health (NIH) to continue researching the damaging effects of alcohol on the nervous systems of the unborn.

27 Aug 2009

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.

27 Aug 2009

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

The Canadian Anesthesiologists' Society (CAS) represents the only trained physicians providing anesthetic services in Canada. CAS is responding to reports that Michael Jackson was given a fatal combination of drugs, including the powerful anesthetic propofol, prior to his death on June 25.

27 Aug 2009

Pain News and Research

Latest Pain News and Research

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Health Net urges Americans to have their blood cholesterol measured

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

Rebuilder Medical Technologies is in concluding stages of finalizing a national contract to provide billing services for all physicians

Inhibitor Education Summits to address pertinent topics regarding hemophilia

New compound discovered by Scripps scientists offers a novel template for drug development

The Waismann Method of Accelerated Benzodiazepine Neuro-Regulation proves a suitable alternative to traditional benzodiazepine detoxification

Two new studies from a federal agency point to risks, costs in health care

ReBuilder Medical Technologies reports 100% increase in second-quarter 2009 profits over first-quarter

WERF to assess the hidden cost of endometriosis to society and women with the disease

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Distribution agreement signed between Cardiovascular Systems and Asahi Intecc

Rutgers University Professor receives $3.5 million MERIT Award from NIH

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pain News and Research

Latest Pain News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in